• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服耐受

Oral tolerance.

作者信息

Wu Henry Yim, Weiner Howard L

机构信息

Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

出版信息

Immunol Res. 2003;28(3):265-84. doi: 10.1385/IR:28:3:265.

DOI:10.1385/IR:28:3:265
PMID:14713719
Abstract

Autoimmune conditions caused by injurious immune responses against self-antigens can be ameliorated if the inappropriate responses to self-components that cause tissue injury can be modulated by regulatory cells or shut off via the induction of anergy or via deletion of pathogenic immune responses. Antigen encounter at the gut mucosa can lead to suppression of injurious immune responses to self-antigen via these mechanisms. This type of immunological event is termed oral tolerance. In this review, we examine the mechanisms behind the induction of oral tolerance and provide findings from its use as a form of treatment for autoimmune diseases.

摘要

如果针对自身抗原的有害免疫反应所引发的自身免疫性疾病,能够通过调节性细胞来调节对自身成分的不适当反应,或者通过诱导无反应性或消除致病性免疫反应来阻断,那么这些疾病就可以得到改善。在肠道黏膜处遇到抗原可通过这些机制抑制对自身抗原的有害免疫反应。这种免疫事件被称为口服耐受。在本综述中,我们研究了诱导口服耐受背后的机制,并提供了将其用作自身免疫性疾病治疗形式的研究结果。

相似文献

1
Oral tolerance.口服耐受
Immunol Res. 2003;28(3):265-84. doi: 10.1385/IR:28:3:265.
2
Oral tolerance: mobilizing the gut.
Hosp Pract (1995). 1995 Sep 15;30(9):53-8. doi: 10.1080/21548331.1995.11443258.
3
Treatment of autoimmune diseases by oral tolerance to autoantigens.通过对自身抗原的口服耐受来治疗自身免疫性疾病。
Adv Exp Med Biol. 1995;371B:1217-23.
4
New treatment avenues: oral tolerance--mechanisms and applicability to human diseases.新的治疗途径:口服耐受——机制及其在人类疾病中的适用性
Isr Med Assoc J. 1999 Sep;1(1):45-9.
5
[Oral tolerance].[口服耐受]
Nihon Rinsho. 2005 Apr;63 Suppl 4:389-94.
6
Oral tolerance and its role in clinical disease.口服耐受及其在临床疾病中的作用。
J Pediatr Gastroenterol Nutr. 2001 Mar;32(3):237-55. doi: 10.1097/00005176-200103000-00003.
7
Oral tolerance to myelin basic protein induces regulatory TGF-beta-secreting T cells in Peyer's patches of SJL mice.对髓鞘碱性蛋白的口服耐受在SJL小鼠的派尔集合淋巴结中诱导分泌调节性转化生长因子β的T细胞。
Cell Immunol. 1994 Sep;157(2):439-47. doi: 10.1006/cimm.1994.1240.
8
[Mechanisms and applications of oral tolerance].[口服耐受的机制与应用]
Z Gastroenterol. 1999 Feb;37(2):165-85.
9
Monocyte chemotactic protein 1 regulates oral tolerance induction by inhibition of T helper cell 1-related cytokines.单核细胞趋化蛋白1通过抑制辅助性T细胞1相关细胞因子来调节口服耐受诱导。
J Exp Med. 1998 Mar 2;187(5):733-41. doi: 10.1084/jem.187.5.733.
10
Oral tolerance: elucidation of mechanisms and application to treatment of autoimmune diseases.口服耐受:机制解析及其在自身免疫性疾病治疗中的应用
Biopolymers. 1997;43(4):323-35. doi: 10.1002/(SICI)1097-0282(1997)43:4<323::AID-BIP5>3.0.CO;2-X.

引用本文的文献

1
Microbiome-Mucosal Immunity Nexus: Driving Forces in Respiratory Disease Progression.微生物群-黏膜免疫关系:呼吸系统疾病进展的驱动因素
J Microbiol. 2024 Sep;62(9):709-725. doi: 10.1007/s12275-024-00167-4. Epub 2024 Sep 6.
2
A White Paper on Collagen Hydrolyzates and Ultrahydrolyzates: Potential Supplements to Support Joint Health in Osteoarthritis?胶原水解物和超水解物白皮书:是否可能成为支持骨关节炎关节健康的补充剂?
Curr Rheumatol Rep. 2021 Oct 30;23(11):78. doi: 10.1007/s11926-021-01042-6.
3
Secretory IgA in Intestinal Mucosal Secretions as an Adaptive Barrier against Microbial Cells.

本文引用的文献

1
The regulation of immune responses to dietary protein antigens.对膳食蛋白质抗原的免疫反应调节。
Immunol Today. 1987;8(3):93-8. doi: 10.1016/0167-5699(87)90853-X.
2
The ingestion of proteins and colloidal materials by columnar absorptive cells of the small intestine in suckling rats and mice.乳鼠和幼鼠小肠柱状吸收细胞对蛋白质和胶体物质的摄取。
J Biophys Biochem Cytol. 1959 Jan 25;5(1):41-50. doi: 10.1083/jcb.5.1.41.
3
Prevention of mucosally induced uveitis with a HSP60-derived peptide linked to cholera toxin B subunit.
肠黏膜分泌液中的分泌型免疫球蛋白 A 作为一种针对微生物细胞的适应性屏障。
Int J Mol Sci. 2020 Dec 4;21(23):9254. doi: 10.3390/ijms21239254.
4
Peculiarities of the formation and subsequent removal of the circulating immune complexes from the bloodstream during the process of digestion.消化过程中循环免疫复合物在血液中形成及随后清除的特点。
F1000Res. 2018 May 21;7:618. doi: 10.12688/f1000research.14406.1. eCollection 2018.
5
Functional heterogeneity of gut-resident regulatory T cells.肠道驻留调节性T细胞的功能异质性
Clin Transl Immunology. 2017 Sep 22;6(9):e156. doi: 10.1038/cti.2017.39. eCollection 2017 Sep.
6
Immunity by equilibrium.平衡免疫。
Nat Rev Immunol. 2016 Aug;16(8):524-32. doi: 10.1038/nri.2016.75. Epub 2016 Jul 11.
7
Protective immunity against Naegleria fowleri infection on mice immunized with the rNfa1 protein using mucosal adjuvants.使用黏膜佐剂用rNfa1蛋白免疫的小鼠对福氏耐格里阿米巴感染的保护性免疫。
Parasitol Res. 2015 Apr;114(4):1377-85. doi: 10.1007/s00436-015-4316-3. Epub 2015 Jan 22.
8
The effect of oral tolerance on the allergic airway response in younger and aged mice.口服耐受对年轻和老年小鼠过敏性气道反应的影响。
J Asthma. 2013 Mar;50(2):122-32. doi: 10.3109/02770903.2012.753455. Epub 2013 Jan 9.
9
Bacillus subtilis: a temperature resistant and needle free delivery system of immunogens.枯草芽孢杆菌:一种耐温、无针的免疫原传递系统。
Hum Vaccin Immunother. 2012 Jul;8(7):979-86. doi: 10.4161/hv.20694. Epub 2012 Jun 15.
10
Strategies of mucosal immunotherapy for allergic diseases.变应性疾病黏膜免疫治疗策略。
Cell Mol Immunol. 2011 Nov;8(6):453-61. doi: 10.1038/cmi.2011.17. Epub 2011 Jun 13.
用与霍乱毒素B亚基相连的热休克蛋白60衍生肽预防黏膜诱导性葡萄膜炎。
Eur J Immunol. 2003 Jan;33(1):224-32. doi: 10.1002/immu.200390025.
4
Induction of low dose oral tolerance in monocyte chemoattractant protein-1- and CCR2-deficient mice.单核细胞趋化蛋白-1和CCR2缺陷小鼠低剂量口服耐受的诱导
J Immunol. 2003 Mar 1;170(5):2316-22. doi: 10.4049/jimmunol.170.5.2316.
5
Suppression of allergic reaction by lambda-carrageenan: toll-like receptor 4/MyD88-dependent and -independent modulation of immunity.λ-角叉菜胶对过敏反应的抑制作用:Toll样受体4/髓样分化因子88依赖和非依赖的免疫调节
Clin Exp Allergy. 2003 Feb;33(2):249-58. doi: 10.1046/j.1365-2222.2003.01575.x.
6
Lack of oral tolerance in aging is due to sequential loss of Peyer's patch cell interactions.衰老过程中口服耐受性的缺失是由于派尔集合淋巴结细胞间相互作用的相继丧失。
Int Immunol. 2003 Feb;15(2):145-58. doi: 10.1093/intimm/dxg011.
7
Oral tolerance induction to Dermatophagoides pteronyssinus and Blomia tropicalis in sensitized mice: occurrence of natural autoantibodies to immunoglobulin E.致敏小鼠对屋尘螨和热带无爪螨的口服耐受诱导:针对免疫球蛋白E的天然自身抗体的出现
Clin Exp Allergy. 2002 Nov;32(11):1667-74. doi: 10.1046/j.1365-2222.2002.01429.x.
8
alpha4 integrins and L-selectin differently orchestrate T-cell activity during diabetes prevention following oral administration of CTB-insulin.口服CTB-胰岛素预防糖尿病期间,α4整合素和L-选择素对T细胞活性的调控方式不同。
J Autoimmun. 2002 Dec;19(4):223-32. doi: 10.1006/jaut.2002.0610.
9
Preventive and therapeutic effects of oral tolerance in a murine model of asthma.口服耐受在小鼠哮喘模型中的预防和治疗作用。
Immunobiology. 2002 Oct;206(4):408-23. doi: 10.1078/0171-2985-00190.
10
Induction of oral tolerance in experimental antiphospholipid syndrome by feeding with polyclonal immunoglobulins.通过喂食多克隆免疫球蛋白诱导实验性抗磷脂综合征中的口服耐受。
Eur J Immunol. 2002 Dec;32(12):3414-24. doi: 10.1002/1521-4141(200212)32:12<3414::AID-IMMU3414>3.0.CO;2-F.